Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage?

Journal of Sexual Medicine

Volumn 6, Issue 5, 2009, Pages 1451-1456

  Sanders, Stephanie A ^a   Milhausen, Robin R ^a,b   Crosby, Richard A ^a,c   Graham, Cynthia A ^a,d,e   Yarber, William L ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Condoms; Erectile dysfunction; Erection; Phosphodiesterase 5 inhibitors; Sexually transmitted infections Risk

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; ADVERTIZING; AGE; ANUS INTERCOURSE; ARTICLE; CONDOM; CONTROLLED STUDY; E-MAIL; ERECTILE DYSFUNCTION; FAMILY SIZE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL ASSESSMENT; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX THERAPY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE;

EID: 65149099133     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01267.x     Document Type: Article

References (21)

1. Bancroft J, Janssen E, Strong D, Carnes L, Vukadinovic Z, Long JS. Sexual risk-taking in gay men: The relevance of sexual arousability. Arch Sex Behav 2003; 32: 555-72.
2. Cove J, Petrak J. Factors associated with sexual problems in HIV-positive gay men. Int J STD AIDS 2004; 15: 732-6.
3. Graham CA, Crosby R, Yarber WL, Sanders SA, McBride K, Milhausen R, etal. Erection loss in association with condom use among young men attending a public STI clinic: Potential correlates and implications for risk behaviour. Sex Health 2006; 3: 1-6.
4. Richters J, Hendry O, Kippax S. When safe sex isn't safe. Cult Health Sex 2003; 5: 37-52.
5. Graham CA, Crosby R, Sanders SA, Yarber WL. Assessment of condom use in men and women. Annu Rev Sex Res 2006; 16: 20-52.
6. Musacchio NS, Hartrich M, Garofalo R. Erectile dysfunction and Viagra use: What's up with college-age males? J Adoles Health 2006; 39: 452-4.
7. Yarber WL, Graham CA, Sanders SA, Crosby RA. Correlates of condom breakage and slippage among undergraduates. Int J STD AIDS 2004; 15: 467-72.
8. Rosen RC, Catania JA, Ehrhardt AA, Burnett AL, Lue TF, McKenna K, Heiman JR, Schwarcz S, Ostrow DG, Hirshfield S, Purcell DW, Fisher WA, Stall R, Halkitis PN, PhD, Latini DM, Elford J, Laumann EO, Sonenstein FL, Greenblatt DJ, Kloner RA, Lee J, Malebranche D, Janssen E, Diaz R, Klausner JD, Caplan AL, Jackson G, Shabsigh R, Khalsa JH, Stoff DM. The Bolger Conference on PDE-5 inhibition and HIV risk: Implications for health policy and prevention. J Sex Med 2006; 3: 960-75.
9. Goldmeier D, Lamba H, Richardson D. Commentary on Rosen RC, Catania JA, Ehrhardt AA, etal. The Bolger Conference on PDE-5 inhibition and HIV risk: Implications for health policy and prevention. J Sex Med 2006; 3: 974.
10. Sadeghi-Nejad H. Commentary on Rosen RC, Catania JA, Ehrhardt AA, etal. The Bolger Conference on PDE-5 inhibition and HIV risk: Implications for health policy and prevention. J Sex Med 2006; 3: 974-5.
11. Korkes F, Costa-Matos A, Gasperini R, Reginato PV, Perez MDC. Recreational use of PDE5 inhibitors by young healthy men: Recognizing this issue among medical students. J Sex Med 2008; 5: 2414-8.
12. Cachy E, Mar-Tang M, Mathews WC. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and Sildenafil use among males entering care for HIV. AIDS Patient Care STDS 2004; 18: 349-54.
13. Cooperman NA, Arnsten JH, Klein RS. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev 2007; 19: 321-33.
14. Mansergh G, Shouse RL, Marks G, Guzman R, Rader M, Buchbinder S, Colfax GN. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Trans Infect 2006; 82: 131-4.
15. Paul JP, Pollack L, Osmond D, Catania JA. Viagra (Sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Dis 2005; 32: 531-3.
16. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the US: Prevalence and predictors. JAMA 1999; 281: 537-44.
17. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
18. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T for the GAAAB Investigators' Group. Sexual problems among women and men aged 40-80years: Prevalence and correlates identified in the Global study of sexual attitudes and behaviors. Intl J Impot Res 2005; 17: 39-57.
19. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Definitions, classification, and epidemiology of sexual dysfunction. In: Lue TF, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F, eds. Sexual Medicine. Sexual dysfunctions in men and women. Paris: Health Publications; 2004: 39-72.
20. National Center for Health Statistics. Key Statistics from the NSFG. Available at: http://www.cdc.gov/nchs/about/major/nsfg/abclist.htm. (accessed August 7, 2008).
21. Crosby RA, Sanders SA, Yarber WL, Graham CA, Dodge B. Condom use errors and problems among college men. Sex Transm Dis 2002; 29: 552-7.